Navigation Links
Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
Date:7/16/2008

merger of Encode Pharmaceuticals. In March 2008, Raptor acquired an exclusive, worldwide license to the intellectual property and development rights for use of Cysteamine and DR Cysteamine for the treatment of NASH. The Company plans to initiate a Phase 2a clinical trial in collaboration with the University of California, San Diego ("UCSD") to evaluate Cysteamine in patients with NASH. In May 2008, Raptor received orphan drug designation from the FDA for DR Cysteamine for the treatment of Huntington's Disease.

About Raptor Pharmaceuticals Corp.

Raptor Pharmaceuticals Corp. ("Raptor") is a development-stage biopharmaceutical company leveraging novel drug-targeting platforms and reformulated therapeutics to improve treatment outcomes among patients with liver disorders, infectious diseases, cancer, and various orphan indications. The Company's clinical division advances internally developed and in-licensed clinical-stage product candidates towards marketing approval and commercialization and is currently involved in clinical trials in patients with aldehyde dehydrogenase ("ALDH2") deficiency as part of Raptor's Convivia(TM) program and nephropathic cystinosis as part of Raptor's DR Cysteamine program. Raptor's preclinical division bioengineers novel drug candidates and drug-targeting platforms derived from the human receptor-associated protein ("RAP") and related proteins to target cancer, neurodegenerative disorders and infectious diseases. Raptor's preclinical programs include HepTide(TM), WntTide(TM) and NeuroTrans(TM).

For additional information, please visit http://www.raptorpharma.com.

FORWARD LOOKING STATEMENTS

This document contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future results of operation or future financial performance, including, but not limit
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
2. Raptor Pharmaceuticals Provides Update of Product Programs
3. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
4. Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections
5. MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine
6. VIA Pharmaceuticals Completes Patient Visits in Phase 2 Carotid Endarterectomy (CEA) Trial
7. Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
10. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
11. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , August 29, 2014 ... participate in the inaugural Tweetchat taking place in ... Worldwide , organised by UBM Live , ... #CPhIChat is a first of its kind global ... across the supply chain, aimed to stimulate conversations ...
(Date:8/28/2014)... Aug. 28, 2014 Reportlinker.com announces ... available in its catalogue: Needle-Free ... http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-2014-2024.html ... technological and commercial prospects What does the ... Visiongain,s brand new report shows you the ...
(Date:8/28/2014)... 2014 /PRNewswire-iReach/ -- CountryFocus: Healthcare, Regulatory and Reimbursement ... (Photo - http://photos.prnewswire.com/prnh/20140828/140879 ) ... Reimbursement Landscape Poland " an essential source of ... healthcare market and provides insights into the demographic, ... the report provides valuable insights into the trends ...
Breaking Medicine Technology:CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 2Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 3Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 4Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 5
... SAN DIEGO and SUNNYVALE, Calif., April 16 ,Pharmacyclics, ... results,demonstrating the anti-tumor activity of PCI-27483, the company,s,small-molecule ... the,Annual Meeting of the American Association for Cancer ... CA., Researchers reported that in animal models ...
... April 16, 2008 A new Mayo,Clinic study ... against,mild cognitive impairment, a disorder of the brain ... study will be presented at the,American Academy of ... Individuals with mild cognitive impairment can function ...
Cached Medicine Technology:Pharmacyclics' Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer 2Pharmacyclics' Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer 3Mayo Clinic Finds Exercise Can Reduce the Risk of Mild Cognitive Impairment 2
(Date:8/29/2014)... 2 PM US Eastern Time)The current method to ... commonly produced in animals, to neutralize the toxin. ... to difficulties in developing, producing and maintaining the ... led by Charles Shoemaker, Ph.D., professor in the ... the Cummings School of Veterinary Medicine at Tufts ...
(Date:8/29/2014)... AB A new study from the research group of ... and the Lawson Health Research Institute (London, ON) has confirmed ... cancer. The study, published in Cell Reports , shows ... of cancer entirely. , Roughly 2 in 5 Canadians ... of them will die of the disease. In 2014, it,s ...
(Date:8/29/2014)... Francisco, CA (PRWEB) August 30, 2014 ... 10 best web conference providers in the online service ... the list were global leaders Webex, GotoMeeting and Infinite. ... the industry users have to determine which provider is ... Essentially, web conference businesses search for compelling consumer goods ...
(Date:8/29/2014)... Honey Gifts, premium Vancouver adult toys retailer, has ... purse-sized adult toys and erotic products. These products are ... carried in a woman’s purse with complete ease. Not ... Gifts is also leak-free and will not make a ... common characteristics of Honey Gifts’ portable toys range. As ...
(Date:8/29/2014)... 2014 Sansego is an ... interactive online community, and a range of personalized coaching ... the way to professional athletes. Crowie has brought together ... with him throughout the majority of his triathlon career. ... the triathlon public. , Sansego provides the following:, ...
Breaking Medicine News(10 mins):Health News:Mice study shows efficacy of new gene therapy approach for toxin exposures 2Health News:Preventing cancer from forming 'tentacles' stops dangerous spread 2Health News:Top10InAction Reveals Best Web Conference Providers 2Health News:Honey Gifts Now Provides Purse Sized Adult Toys in Vancouver 2Health News:5 x World Champion Triathlete, Craig “Crowie” Alexander, Launches Online Triathlon Coaching Company – Sansego 2Health News:5 x World Champion Triathlete, Craig “Crowie” Alexander, Launches Online Triathlon Coaching Company – Sansego 3
... ANGELES, Sept. 21 Former House Majority leader Tom Delay, who injured ... all on the line when he and dance partner Cheryl Burke, a ... network. , , Last week, Delay was ... in Marina del Rey, Calif. headed by Dr. Robert S. Bray, Jr., ...
... poor decisions long after they were sober , MONDAY, Sept. ... that doing JELL-O shots is never a good idea, adolescent ... risky decisions long after the alcohol had worn off. , ... teenagers who drink to excess could experience similar, long-lasting effects. ...
... , GARDEN CITY, N.Y., Sept. 21 ... Member for District 12 in the Bronx, celebrated an evening ... than 700 residents from Co-Op City joined in the salute ... Mayor David Dinkins, Roscoe Brown, MD, Floyd J. Carter, Bishop ...
... WASHINGTON, Sept. 21 Trust for America,s Health (TFAH) and ... report today featuring a range of evidence-based disease prevention programs ... in communities. , , The Compendium ... and examples from an extensive literature review that NYAM conducted ...
... both open surgery and minimally invasive techniques, study finds ... of nasal fractures is possible using either minimally invasive ... procedure is appropriate for the type of fracture, researchers ... taking into account factors such as fracture type and ...
... care is delayed, complicated and even jeopardized because ... The situation is particularly dire in diverse megacities ... USC computer scientists, communication specialists and health professionals ... speech-to-speech (S2S) translation system for clinics, emergency rooms ...
Cached Medicine News:Health News:Injured Tom Delay to Put Foot to Test in Debut of Dancing With the Stars Premiere Tonight on ABC 2Health News:Drinking in Adolescence May Lead to Risky Choices Later 2Health News:Drinking in Adolescence May Lead to Risky Choices Later 3Health News:HealthCare Partners, IPA, Dr. Richard Merkin, CEO and Councilman Larry Seabrook Celebrate Salute to Our Heroes on 9/11 2Health News:HealthCare Partners, IPA, Dr. Richard Merkin, CEO and Councilman Larry Seabrook Celebrate Salute to Our Heroes on 9/11 3Health News:New Report Highlights Proven Disease Prevention Programs in Communities 2Health News:New Report Highlights Proven Disease Prevention Programs in Communities 3Health News:New Report Highlights Proven Disease Prevention Programs in Communities 4Health News:Best Option for Fractured Nose Varies by Patient 2Health News:'The doctor can understand you now' 2Health News:'The doctor can understand you now' 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: